NEUARTIGE EGFR-VARIANTE

Patent europeic · EP2956554 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2956554
Numer da la dumonda
EP14751442
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
14-02-2014
Publitgà
23-12-2015
Concedì
09-10-2019
Stritgà
29-02-2020
Motiv
Taxa annuala betg pajada
Classas IPC
C12Q 1/6886 (2018.01)
C07K 14/71 (2006.01)
G01N 33/574 (2006.01)
C07K 16/28 (2006.01)
C07K 14/485 (2006.01)
C12N 15/113 (2010.01)
Prioritad
US 201361765537 P 15.02.2013
Dumonda PCT
PCT/US2014/016536 14.02.2014
Publicaziun PCT
WO2014/127266 21.08.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.09.2020

  2. 12-02-2020

    Owner

    Owner
    Exosome Diagnostics Inc., The Lasker Biomedical Research Building, 3960 Broadway, Suite 540, New York, NY 10032, USA → Exosome Diagnostics, Inc., 266 Second Avenue, Suite 200, Waltham, MA 02451, USA

    Published in Swissreg on 12.02.2020

  3. 09-10-2019

    Concedì

    Published in Swissreg on 09.10.2019

Partidas

Inventur

SKOG, Johan, Karl, Olov

Charlestown, MA 02129, US

BERGHOFF, Emily

Cambridge, MA 02139, US

LOGUIDICE, Lori

Cambridge, MA 02139, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.